CCK-8-evoked cationic currents in substantia nigra dopaminergic neurons are mediated by InsP3-induced Ca2+ release

Neurosci Lett. 1994 Jul 4;175(1-2):95-8. doi: 10.1016/0304-3940(94)91087-1.

Abstract

Our recent study demonstrated that by activating CCK-A receptors, CCK-8 excites substantia nigra (SN) dopaminergic (DA) neurons via increasing a non-selective cationic conductance. In the present study, we further studied the molecular mechanism by which CCK-8 induces cationic currents in SN DA neurons. CCK-8-evoked inward currents were inhibited by the intracellular perfusion of GDP-beta-S (1 mM). In DA neurons internally perfused with GTP-gamma-S (0.5 mM), the inward currents produced by CCK-8 became irreversible. Pretreating DA neurons with 500 ng/ml pertussis toxin (PTX) did not significantly affect the ability of CCK-8 to induce cationic currents. Intracellular application of heparin (2 mg/ml), an inositol 1,4,5-trisphosphate (InsP3) receptor antagonist, and buffering intracellular calcium with the Ca(2+)-chelator BAPTA (10 mM) suppressed CCK-8-evoked cationic currents. Dialyzing DA neurons with protein kinase C (PKC) inhibitors, staurosporine and PKC(19-31), failed to prevent CCK-8 from generating cationic currents. It is concluded that PTX-insensitive G-proteins mediate CCK-8-induced enhancement of cationic conductance of SN DA neurons. The coupling mechanism via G-proteins is likely to involve the generation of InsP3, and subsequent InsP3-evoked Ca2+ release from the intracellular store results in activating the non-selective cationic conductance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / pharmacology
  • Animals
  • Calcium / metabolism*
  • Calcium Channels / drug effects
  • Dopamine / metabolism*
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Evoked Potentials / drug effects
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Guanosine Diphosphate / analogs & derivatives
  • Guanosine Diphosphate / pharmacology
  • Heparin / pharmacology
  • In Vitro Techniques
  • Inositol 1,4,5-Trisphosphate / physiology*
  • Inositol 1,4,5-Trisphosphate Receptors
  • Ion Channels / drug effects
  • Ion Channels / physiology*
  • Neurons / drug effects
  • Neurons / physiology*
  • Peptide Fragments / pharmacology
  • Pertussis Toxin
  • Protein Kinase C / antagonists & inhibitors
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Cytoplasmic and Nuclear / drug effects
  • Sincalide / pharmacology*
  • Staurosporine
  • Substantia Nigra / physiology*
  • Thionucleotides / pharmacology
  • Time Factors
  • Virulence Factors, Bordetella / pharmacology

Substances

  • Alkaloids
  • Calcium Channels
  • Inositol 1,4,5-Trisphosphate Receptors
  • Ion Channels
  • Peptide Fragments
  • Receptors, Cytoplasmic and Nuclear
  • Thionucleotides
  • Virulence Factors, Bordetella
  • Guanosine Diphosphate
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Egtazic Acid
  • guanosine 5'-O-(2-thiodiphosphate)
  • Inositol 1,4,5-Trisphosphate
  • Heparin
  • Pertussis Toxin
  • Protein Kinase C
  • Staurosporine
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Sincalide
  • Calcium
  • Dopamine